Business Daily Media

BioLargo, Inc. Discusses 125% Revenue Increase for 2022 with The Stock Day Podcast

  • Written by Newsfile

Phoenix, Arizona--(Newsfile Corp. - January 31, 2023) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO), a company that invents, develops, and commercializes innovative technologies in the cleantech space, including for PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. President and CEO of the company, Dennis P. Calvert, joined Stock Day host Everett Jolly for an interview.

Jolly began by commenting on BioLargo's 125% increase in revenues in 2022 compared to 2021, and asked about the catalysts for this increase. Calvert explained that among the company's portfolio of proprietary life sciences technologies is its disruptive odor control technology that is experiencing dramatic revenue growth due in large part to the success of a consumer product goods partnership (www.pooph.com[1]) that has launched a pet odor product that is enjoying growing success in online sales and in retailers like Walmart.

He added, "The [company's] engineering group itself is also finding significance in customer adoption for their services, so it has been the combination of both," shared Calvert. "As our overhead stays relatively fixed, all of a sudden we have cash flow, and that is a great thing for BioLargo."

"The key is the adoption of products and services that can scale, and that is what we're witnessing."

"Could you give us an update on your PFAS treatment technology?" asked Jolly. "Basically, the machine creates an electric field and as the water flows through the machine, the PFAS is drawn to its opposite charge," explained Calvert. "[The PFAS] is collected to extract it and take it out of the water," he added. "It is able to create a non-detect status, which means it can take it all out," said Calvert, adding that BioLargo secured its first customer for PFAS mitigation services in August 2022.

"What are you most excited about for 2023?" asked Jolly. "We're looking forward to selling more of our products and services."

To hear Dennis Calvert's entire interview, follow the link to the podcast here: https://audioboom.com/posts/8239346-biolargo-inc-discusses-125-revenue-increase-for-2022-with-the-stock-day-podcast[2].

Investors Hangout[3] is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/[4].

About BioLargo, Inc.

BioLargo, Inc. (OTCQB: BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com[5].

Contact InformationDennis P. Calvert President and CEO, BioLargo, Inc. 888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue and plans for future operations, and may be identified by words such as "we believe". These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of the COVID-19 pandemic on the Company's business, results of operations, financial condition, and stock price; the effect of global and regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

About The "Stock Day" Podcast

Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America.

SOURCE:Stock Day Media(602) 821-1102

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/153041[6]

Read more https://www.newsfilecorp.com/release/153041/BioLargo-Inc.-Discusses-125-Revenue-Increase-for-2022-with-The-Stock-Day-Podcast